Rosalind Advisors, Inc. 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 4:57 pm Purchase |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 7,472,745 9.900% |
502,320 (+7.21%) |
Filing |
| 2024-08-14 7:15 pm Purchase |
2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 6,970,425 9.900% |
2,977,839 (+74.58%) |
Filing |
| 2024-07-11 5:37 pm Unchanged |
2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 3,992,586 9.900% |
0 (Unchanged) |
Filing |
| 2024-04-25 8:01 pm Sale |
2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 3,992,586 9.900% |
-2,684,347 (-40.20%) |
Filing |
| 2024-02-14 8:31 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 6,676,933 9.900% |
4,518,661 (+209.36%) |
Filing |
| 2023-02-13 5:53 pm Unchanged |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 2,158,272 9.970% |
0 (Unchanged) |
Filing |
| 2022-11-02 8:03 pm Purchase |
2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 2,158,272 9.970% |
1,553,044 (+256.60%) |
Filing |
| 2022-01-21 3:49 pm Purchase |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 605,228 9.970% |
284,512 (+88.71%) |
Filing |
| 2021-07-08 1:30 pm Purchase |
2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 320,716 6.000% |
320,716 (New Position) |
Filing |